Literature DB >> 21474900

Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.

Bill H McCarberg1.   

Abstract

Pain is among the most common reasons patients seek medical attention, and the care of patients with pain is a significant problem in the United States. Acute pain (mild-to-moderate intensity) represents one of the most frequent complaints encountered by primary care physicians (PCPs) and accounts for nearly half of patient visits. However, the overall quality of pain management remains unacceptable for millions of US patients with acute or chronic pain, and underrecognition and undertreatment of pain are of particular concern in primary care. Primary care physicians face dual challenges from the emerging epidemics of undertreated pain and prescription opioid abuse. Negative impacts of untreated pain on patient activities of daily living and public health expenditures, combined with the success of opioid analgesics in treating pain provide a strong rationale for PCPs to learn best practices for pain management. These clinicians must address the challenge of maintaining therapeutic access for patients with a legitimate medical need for opioids, while simultaneously minimizing the risk of abuse and addiction. Safe and effective pain management requires clinical skill and knowledge of the principles of opioid treatment as well as the effective assessment of risks associated with opioid abuse, addiction, and diversion. Easily implementable patient selection and screening, with selective use of safeguards, can mitigate potential risks of opioids in the busy primary practice setting. Primary care physicians can become advocates for proper pain management and ensure that all patients with pain are treated appropriately.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474900     DOI: 10.3810/pgm.2011.03.2270

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  10 in total

1.  Clinical implications of drug abuse epidemiology.

Authors:  Jeffrey D Schulden; Marsha F Lopez; Wilson M Compton
Journal:  Psychiatr Clin North Am       Date:  2012-06

2.  Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.

Authors:  Matthew Daubresse; Hsien-Yen Chang; Yuping Yu; Shilpa Viswanathan; Nilay D Shah; Randall S Stafford; Stefan P Kruszewski; G Caleb Alexander
Journal:  Med Care       Date:  2013-10       Impact factor: 2.983

3.  Longer-term remedies for chronic pain management.

Authors:  Amol Deshpande; Angela Mailis
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

4.  Naloxone-reversible modulation of pain circuitry by left prefrontal rTMS.

Authors:  Joseph J Taylor; Jeffrey J Borckardt; Melanie Canterberry; Xingbao Li; Colleen A Hanlon; Truman R Brown; Mark S George
Journal:  Neuropsychopharmacology       Date:  2013-01-11       Impact factor: 7.853

5.  Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain.

Authors:  Martin E Hale; Srinivas R Nalamachu; Arif Khan; Michael Kutch
Journal:  J Pain Res       Date:  2013-05-01       Impact factor: 3.133

6.  The pain crisis: what it is and what can be done.

Authors:  Barry J Sessle
Journal:  Pain Res Treat       Date:  2012-09-19

7.  Physician assessments of drug seeking behavior: A mixed methods study.

Authors:  Michael A Fischer; John B McKinlay; Jeffrey N Katz; Eric Gerstenberger; Felicia Trachtenberg; Lisa D Marceau; Lisa C Welch
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

8.  Analgesic effects of Marasmius androsaceus mycelia ethanol extract and possible mechanisms in mice.

Authors:  Jia Song; Xue Wang; Yu Huang; Yidi Qu; Guirong Zhang; Di Wang
Journal:  Braz J Med Biol Res       Date:  2018-03-01       Impact factor: 2.590

9.  Evaluation of antinociceptive activity of Ilex dipyrena Wall. in mice.

Authors:  Amjad Ali; Abdul Nasir; Syed Wadood Ali Shah; Atif Ali Khan Khalil; Mi-Jeong Ahn; Syed Muhammad Mukarram Shah; Fazli Subhan; Muhammad Faheem; Wasim Sajjad; Mohammad Shoaib; Saeed Ahmad; Nausheen Nazir; Mohammad Nisar
Journal:  BMC Complement Med Ther       Date:  2021-07-01

10.  Pharmacological Profiles of Oligomerized μ-Opioid Receptors.

Authors:  Cynthia Wei-Sheng Lee; Ing-Kang Ho
Journal:  Cells       Date:  2013-10-11       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.